Consolidated Portfolio Review Corp Clover Health Investments, Corp. Transaction History
Consolidated Portfolio Review Corp
- $723 Billion
- Q2 2025
A detailed history of Consolidated Portfolio Review Corp transactions in Clover Health Investments, Corp. stock. As of the latest transaction made, Consolidated Portfolio Review Corp holds 37,574 shares of CLOV stock, worth $113,097. This represents 0.01% of its overall portfolio holdings.
Number of Shares
37,574Holding current value
$113,097% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding CLOV
# of Institutions
221Shares Held
108MCall Options Held
3.1MPut Options Held
2.12M-
Vanguard Group Inc Valley Forge, PA20.6MShares$61.9 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny11MShares$33.2 Million0.06% of portfolio
-
Black Rock Inc. New York, NY9.54MShares$28.7 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.8MShares$17.5 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.03MShares$15.1 Million0.0% of portfolio
About CLOVER HEALTH INVESTMENTS, CORP.
- Ticker CLOV
- Exchange NASDAQ
- Sector Healthcare
- Industry Healthcare Plans
- Shares Outstandng 383,248,000
- Market Cap $1.15B
- Description
- Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health In...